Detalhe da pesquisa
1.
24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo.
J Biol Chem
; 294(11): 4169-4176, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655290
2.
Altered plasma protein profiles in genetic FTD - a GENFI study.
Mol Neurodegener
; 18(1): 85, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37968725
3.
TBK1 haploinsufficiency results in changes in the K63-ubiquitination profiles in brain and fibroblasts from affected and presymptomatic mutation carriers.
J Neurol
; 269(6): 3037-3049, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800171
4.
Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: a pilot study.
Ann Clin Transl Neurol
; 8(3): 579-591, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476461
5.
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.
Mol Neurodegener
; 16(1): 79, 2021 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838088
6.
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
Nat Commun
; 12(1): 3417, 2021 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099642
7.
Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.
Transl Neurodegener
; 9(1): 27, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576262
8.
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
Nat Commun
; 14(1): 716, 2023 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759603